BlueHealer Inc. — SEC Form D Filing
BlueHealer Inc. filed an SEC Form D on November 4, 2026, reporting $1 raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- November 4, 2026
- Amount reported
- $1
- Round stage
- Pre-seed, as BlueHealer was incorporated in 2024 and has relied primarily on initial non-dilutive grant funding alongside a nominal equity filing.
- Industry
- Biotechnology
- Website
- https://www.bluehealer.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients suffering from severe peripheral arterial disease and chronic lower-limb wounds face high rates of amputation due to poor blood circulation and complications from traditional external surgical frames.
Solution
BlueHealer develops an internal implantable orthopedic device for tibial transverse transport that stimulates blood flow to preserve limbs while avoiding the infection and fracture risks of external fixation.
Why now
Surging global rates of diabetic vascular complications combined with advances in minimally invasive internal orthopedic hardware have created strong clinical demand for safer limb-salvage solutions.
Source: SEC EDGAR Form D filing